Subjects -> HEALTH AND SAFETY (Total: 1464 journals)
    - CIVIL DEFENSE (22 journals)
    - DRUG ABUSE AND ALCOHOLISM (87 journals)
    - HEALTH AND SAFETY (686 journals)
    - HEALTH FACILITIES AND ADMINISTRATION (358 journals)
    - OCCUPATIONAL HEALTH AND SAFETY (112 journals)
    - PHYSICAL FITNESS AND HYGIENE (117 journals)
    - WOMEN'S HEALTH (82 journals)

DRUG ABUSE AND ALCOHOLISM (87 journals)

Showing 1 - 85 of 85 Journals sorted alphabetically
Addiction     Hybrid Journal   (Followers: 50)
Addiction Biology     Hybrid Journal   (Followers: 16)
Addiction Neuroscience     Open Access   (Followers: 1)
Addiction Research & Theory     Hybrid Journal   (Followers: 29)
Addictive Behaviors     Hybrid Journal   (Followers: 18)
Addictive Behaviors Reports     Open Access   (Followers: 9)
Addictive Disorders & Their Treatment     Hybrid Journal   (Followers: 6)
Adicciones     Open Access   (Followers: 1)
Advances in Dual Diagnosis     Hybrid Journal   (Followers: 45)
African Journal of Drug and Alcohol Studies     Full-text available via subscription   (Followers: 5)
Alcohol     Hybrid Journal   (Followers: 12)
Alcohol and Alcoholism     Hybrid Journal   (Followers: 18)
Alcoholism and Drug Abuse Weekly     Hybrid Journal   (Followers: 8)
Alcoholism Clinical and Experimental Research     Hybrid Journal   (Followers: 9)
Alcoholism Treatment Quarterly     Hybrid Journal   (Followers: 5)
American Journal of Drug and Alcohol Abuse     Hybrid Journal   (Followers: 18)
American Journal on Addictions     Hybrid Journal   (Followers: 11)
Avicenna Journal of Neuro Psycho Physiology     Open Access  
Bereavement Care     Hybrid Journal   (Followers: 13)
Canadian Journal of Addiction     Hybrid Journal   (Followers: 7)
Child Abuse Review     Hybrid Journal   (Followers: 14)
Clinical Toxicology     Hybrid Journal   (Followers: 18)
Contemporary Drug Problems     Full-text available via subscription   (Followers: 2)
Critical Gambling Studies     Open Access  
Current Addiction Reports     Hybrid Journal   (Followers: 16)
Drug and Alcohol Dependence     Hybrid Journal   (Followers: 20)
Drug and Alcohol Dependence Reports     Open Access   (Followers: 5)
Drug and Alcohol Review     Full-text available via subscription   (Followers: 17)
Drug Intoxication & Detoxification : Novel Approaches     Full-text available via subscription   (Followers: 1)
Drugs     Full-text available via subscription   (Followers: 143)
Drugs and Alcohol Today     Hybrid Journal   (Followers: 149)
Drugs: education, prevention and policy     Hybrid Journal   (Followers: 11)
Emerging Trends in Drugs, Addictions, and Health     Open Access   (Followers: 1)
European Addiction Research     Full-text available via subscription   (Followers: 19)
Expert Opinion on Drug Metabolism & Toxicology     Hybrid Journal   (Followers: 14)
Expert Opinion on Drug Safety     Hybrid Journal   (Followers: 12)
Forensic Toxicology     Hybrid Journal   (Followers: 19)
Global Crime     Hybrid Journal   (Followers: 283)
Health Communication     Hybrid Journal   (Followers: 17)
International Gambling Studies     Hybrid Journal   (Followers: 8)
International Journal of Alcohol and Drug Research     Open Access   (Followers: 8)
International Journal of Drug Policy     Hybrid Journal   (Followers: 251)
International Journal of High Risk Behaviors and Addiction     Open Access   (Followers: 15)
International Journal of Mental Health and Addiction     Hybrid Journal   (Followers: 28)
International Journal of Prevention and Treatment of Substance Use Disorders     Open Access   (Followers: 6)
Journal of Addiction     Open Access   (Followers: 18)
Journal of Addiction Science     Open Access   (Followers: 3)
Journal of Addictions & Offender Counseling     Partially Free   (Followers: 6)
Journal of Addictions Nursing     Hybrid Journal   (Followers: 8)
Journal of Addictive Behaviors, Therapy & Rehabilitation     Hybrid Journal   (Followers: 6)
Journal of Addictive Diseases     Hybrid Journal   (Followers: 5)
Journal of Behavioral Health Services & Research     Hybrid Journal   (Followers: 15)
Journal of Child & Adolescent Substance Abuse     Hybrid Journal   (Followers: 21)
Journal of Drug Education     Full-text available via subscription   (Followers: 9)
Journal of Drug Issues     Hybrid Journal   (Followers: 2)
Journal of Dual Diagnosis     Hybrid Journal   (Followers: 4)
Journal of Emotional Abuse     Hybrid Journal   (Followers: 2)
Journal of Ethnicity in Substance Abuse     Hybrid Journal   (Followers: 13)
Journal of Evidence-Based Social Work     Hybrid Journal   (Followers: 28)
Journal of Gambling Studies     Hybrid Journal   (Followers: 4)
Journal of Groups in Addiction & Recovery     Hybrid Journal   (Followers: 8)
Journal of Psychoactive Drugs     Hybrid Journal   (Followers: 6)
Journal of Social Work Practice in the Addictions     Hybrid Journal   (Followers: 12)
Journal of Social Work Practice: Psychotherapeutic Approaches in Health, Welfare and the Community     Hybrid Journal   (Followers: 14)
Journal of Studies on Alcohol and Drugs     Full-text available via subscription   (Followers: 2)
Journal of Substance Abuse Treatment     Hybrid Journal   (Followers: 45)
Journal of Substance Use     Hybrid Journal   (Followers: 13)
Journal of Teaching in the Addictions     Hybrid Journal   (Followers: 2)
Juvenile and Family Court Journal     Hybrid Journal   (Followers: 33)
Land Use Policy     Hybrid Journal   (Followers: 28)
Mental Health and Substance Use: dual diagnosis     Hybrid Journal   (Followers: 24)
Nanotoxicology     Hybrid Journal   (Followers: 2)
Nicotine & Tobacco Research     Hybrid Journal   (Followers: 14)
OA Alcohol     Open Access   (Followers: 4)
Psychology of Addictive Behaviors     Full-text available via subscription   (Followers: 15)
Revista Inspirar     Open Access  
Salud y Drogas     Open Access  
SMAD, Revista Electronica en Salud Mental, Alcohol y Drogas     Open Access   (Followers: 2)
Substance Abuse     Hybrid Journal   (Followers: 10)
Substance Abuse and Rehabilitation     Open Access   (Followers: 6)
Substance Abuse Treatment, Prevention and Policy     Open Access   (Followers: 9)
Substance Use & Misuse     Hybrid Journal   (Followers: 9)
SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice     Hybrid Journal   (Followers: 4)
The Brown University Digest of Addiction Theory and Application     Hybrid Journal   (Followers: 5)
Toxicodependências     Open Access  
Similar Journals
Journal Cover
Expert Opinion on Drug Safety
Journal Prestige (SJR): 1.112
Citation Impact (citeScore): 3
Number of Followers: 12  
 
Hybrid Journal Hybrid journal   * Containing 9 Open Access Open Access article(s) in this issue *
ISSN (Print) 1474-0338 - ISSN (Online) 1744-764X
Published by Taylor and Francis Homepage  [2652 journals]
  • Superior stroke prevention with angiotensin receptor blockers compared
           with other antihypertensive drugs

    • Free pre-print version: Loading...

      Authors: Steven G. Chrysant
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-10T06:11:17Z
      DOI: 10.1080/14740338.2023.2189236
       
  • Impact of regulatory safety warnings and restrictions on drug treatment of
           epilepsy

    • Free pre-print version: Loading...

      Authors: Amanda W. Pong, Ivana Tyrlikova, Alexander J. Giermek, Pavel Klein
      Pages: 1 - 4
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-10T06:09:13Z
      DOI: 10.1080/14740338.2023.2188189
       
  • Ocular adverse events associated with BRAF and MEK inhibitor combination
           therapy: a pharmacovigilance disproportionality analysis of the FDA
           adverse event reporting system

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Shuohan Huang, Zihan Guo, Mengmeng Wang, Youjun She, Xuan Ye, Qing Zhai, Jiyong Liu, Qiong Du
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-10T02:00:48Z
      DOI: 10.1080/14740338.2023.2189235
       
  • Safety and cardiometabolic efficacy of novel antidiabetic drugs

    • Free pre-print version: Loading...

      Authors: Liana Michaud, Matthew Seplowe, Juliet Meir, Wilbert S. Aronow
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-08T06:02:38Z
      DOI: 10.1080/14740338.2023.2188190
       
  • Performance of subgrouped proportional reporting ratios in the US Food and
           Drug Administration (FDA) adverse event reporting system

    • Free pre-print version: Loading...

      Authors: Daniel G. Dauner, Rui Zhang, Terrence J. Adam, Eleazar Leal, Viviene Heitlage, Joel F. Farley
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-07T01:29:59Z
      DOI: 10.1080/14740338.2023.2182289
       
  • The safety and efficacy of interleukin 11 for radiation injury

    • Free pre-print version: Loading...

      Authors: Vijay K. Singh, Thomas M Seed
      Pages: 1 - 5
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-03T01:35:34Z
      DOI: 10.1080/14740338.2023.2185604
       
  • Sex differences in adverse drug reactions from Adalimumab and etanercept
           in patients with inflammatory rheumatic diseases

    • Free pre-print version: Loading...

      Authors: Helen R. Gosselt, Jette A. van Lint, Leanne J. Kosse, Phyllis I. Spuls, Harald E. Vonkeman, Sander W. Tas, Frank Hoentjen, Michael T. Nurmohamed, Bart J.F. van den Bemt, Martijn B.A. van Doorn, Naomi T. Jessurun
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-02T06:59:43Z
      DOI: 10.1080/14740338.2023.2181340
       
  • Potential drug-drug interactions in adults receiving oral anticoagulant
           and antiaggregant therapy

    • Free pre-print version: Loading...

      Authors: Sema Ketenci, Gökçe Akpınar
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-03-02T06:43:32Z
      DOI: 10.1080/14740338.2023.2186397
       
  • The risk of all-cause death with dapagliflozin versus placebo: a
           systematic review and meta-analysis of phase III randomized controlled
           trials

    • Free pre-print version: Loading...

      Authors: Hai-Bin Chen, Rong-Sen Meng, Yao-Lin Yang, Tian-Hao Yu
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-27T05:29:42Z
      DOI: 10.1080/14740338.2023.2182290
       
  • Risks of cardiovascular toxicities associated with ALK tyrosine kinase
           inhibitors in patients with non-small-cell lung cancer: a meta-analysis of
           randomized control trials

    • Free pre-print version: Loading...

      Authors: Jin Zhao, Zhuo Ma, Hao Li, Dan Sun, Yi Hu, Chen Zhang, Yuhui Zhang
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-27T05:25:40Z
      DOI: 10.1080/14740338.2023.2182284
       
  • Identification of adverse drug reactions that may be related to
           pharmacogenetics in a public hospital in the South of Brazil

    • Free pre-print version: Loading...

      Authors: Amanda C. Camargo, Ursula Matte, Mariana R. Botton
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-27T05:21:39Z
      DOI: 10.1080/14740338.2023.2181337
       
  • Application of tree-based machine learning classification methods to
           detect signals of fluoroquinolones using the Korea Adverse Event Reporting
           System (KAERS) database

    • Free pre-print version: Loading...

      Authors: Min-Gyo Jang, SangHun Cha, Seunghwak Kim, Sojung Lee, Kyeong Eun Lee, Kwang-Hee Shin
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-24T06:04:19Z
      DOI: 10.1080/14740338.2023.2181341
       
  • Safety of romiplostim and eltrombopag for children with immune
           thrombocytopenia: a pharmacovigilance study of the FDA adverse event
           reporting system database

    • Free pre-print version: Loading...

      Authors: Qiongtong Fang, Fuqiang Huang, Jiabi Liang, Yishen Chen, Cheng Li, Meirong Zhang, Xinrong Wu, Wenji Luo
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-24T06:04:17Z
      DOI: 10.1080/14740338.2023.2182288
       
  • Thromboembolism profiles associated with cyclin-dependent kinase 4/6
           inhibitors: a real-world pharmacovigilance study and a systematic review

    • Free pre-print version: Loading...

      Authors: Siyuan Gao, Yu Li, Zhichao He, Jianhong Zhu, Dan Liang, Shan Yang, Jiayao Mo, Kakei Lam, Xiaoxia Yu, Ming Huang, Junyan Wu
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-24T05:54:13Z
      DOI: 10.1080/14740338.2023.2181338
       
  • Possible genetical predictors of efficacy and safety of budesonide-MMX in
           patients with mild-to-moderate ulcerative colitis, and safety comparison
           with methylprednisolone

    • Free pre-print version: Loading...

      Authors: Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-24T05:49:33Z
      DOI: 10.1080/14740338.2023.2181336
       
  • Development and validation of a nomogram to predict the risk of
           potentially inappropriate medication use in older lung cancer outpatients
           with multimorbidity

    • Free pre-print version: Loading...

      Authors: Fangyuan Tian, Zhaoyan Chen, Bin Wu
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-23T05:07:38Z
      DOI: 10.1080/14740338.2023.2183191
       
  • Safety implications of concomitant administration of antidepressants and
           opioid analgesics in surgical patients

    • Free pre-print version: Loading...

      Authors: Rosa Rodriguez-Monguio, Zhixin Lun, Drew T Dickinson, Connie Do, Bailey Hyland, Eline Kocharyan, Leanne Liu, Michael A Steinman
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-23T05:06:58Z
      DOI: 10.1080/14740338.2023.2181333
       
  • Hepatitis B virus reactivation associated with Janus kinase (JAK)
           inhibitors: a retrospective study of pharmacovigilance databases and
           review of the literature

    • Free pre-print version: Loading...

      Authors: Chen Pan, Mingnan Cao, Cilin Yan, Xiaojuan Ou, Xia Zhang, Wanyi Xu, Ye Xu, Xiangli Cui
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-22T06:25:59Z
      DOI: 10.1080/14740338.2023.2181339
       
  • Safety and effectiveness of rivaroxaban for prevention of stroke in
           patients with nonvalvular atrial fibrillation: analysis of routine
           clinical data from four countries

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink, Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Kiliana Suzart-Woischnik, Gunnar Brobert, Ron M. C. Herings
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-22T02:06:18Z
      DOI: 10.1080/14740338.2023.2181334
       
  • Medication errors during a pandemic: what have we learnt'

    • Free pre-print version: Loading...

      Authors: Ahmad Z. Al Meslamani
      Pages: 1 - 4
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-22T01:22:10Z
      DOI: 10.1080/14740338.2023.2181954
       
  • Safety evaluation of axicabtagene ciloleucel for relapsed or refractory
           large B-cell lymphoma

    • Free pre-print version: Loading...

      Authors: Karthik Nath, Kitsada Wudhikarn, Ana Alarcon Tomas, Miguel-Angel Perales
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-17T01:14:44Z
      DOI: 10.1080/14740338.2023.2177268
       
  • Safety of medications for hereditary angioedema during pregnancy and
           lactation

    • Free pre-print version: Loading...

      Authors: Andrew Yeich, Ahmed Elhatw, Zaynab Ashoor, Kristen Park, Timothy Craig
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-16T07:54:10Z
      DOI: 10.1080/14740338.2023.2177269
       
  • Ubrogepant and rimegepant: systematic review, meta-analysis, and
           meta-regression of clinical studies

    • Free pre-print version: Loading...

      Authors: Guojun Dong, Naoko Adachi Kjærgaard, Saeed Shakibfar, Maurizio Sessa
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-13T06:40:14Z
      DOI: 10.1080/14740338.2023.2177270
       
  • Can COVID-19 have a clinically significant effect on drug metabolism'

    • Free pre-print version: Loading...

      Authors: Felicia Ceban, Mehala Subramaniapillai, Joshua D. Rosenblat, Rodrigo B. Mansur, Roger S. McIntyre
      Pages: 1 - 3
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-06T05:37:03Z
      DOI: 10.1080/14740338.2023.2172158
       
  • Efficacy and safety of biologics and small molecules for psoriasis in
           pediatric and geriatric populations. Part II: focus on elderly patients

    • Free pre-print version: Loading...

      Authors: Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini, Luca Potestio
      Pages: 1 - 16
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-03T06:03:43Z
      DOI: 10.1080/14740338.2023.2173171
       
  • The impact of pharmacist intervention on the intravenous-to-oral switch
           therapy of proton pump inhibitors in cardiovascular surgery

    • Free pre-print version: Loading...

      Authors: Jianan Bao, Ling Zhou, Mengying Xu, Jingjing Ma
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-02T08:34:11Z
      DOI: 10.1080/14740338.2023.2172162
       
  • Gastrointestinal disorders potentially associated with Semaglutide: an
           analysis from the Eudravigilance Database

    • Free pre-print version: Loading...

      Authors: António Cabral Lopes, Fátima Roque, Olga Lourenço, Maria Teresa Herdeiro, Manuel Morgado
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-02T08:29:12Z
      DOI: 10.1080/14740338.2023.2172159
       
  • Efficacy and safety of biologics and small molecules for psoriasis in
           pediatric and geriatric populations. Part I: focus on pediatric patients

    • Free pre-print version: Loading...

      Authors: Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini, Luca Potestio
      Pages: 1 - 17
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-02-02T06:08:10Z
      DOI: 10.1080/14740338.2023.2173170
       
  • Letter to the editor: consideration on: ‘What is the risk of
           cardiovascular events in osteoporotic patients treated with
           romosozumab'’ by Reid I.R

    • Free pre-print version: Loading...

      Authors: Marco Di Monaco, Carlotta Castiglioni, Francesca Bardesono
      Pages: 1 - 2
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-01-30T05:47:32Z
      DOI: 10.1080/14740338.2023.2173737
       
  • Evaluating the Impact of Black Box Warning Updates on the Reporting of
           Drug-Related Adverse Events: a Cross Sectional Study of the FAERS Database
           

    • Free pre-print version: Loading...

      Authors: Yarden Yavne, Reut Amar Shamir, Michael Shapiro, Daniel Shepshelovich
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-01-27T12:26:59Z
      DOI: 10.1080/14740338.2023.2172160
       
  • First-time adverse drug reactions, survival analysis, and the share of
           adverse drug reactions in treatment discontinuation in real-world
           rheumatoid arthritis patients: a comparison of first-time treatment with
           adalimumab and etanercept

    • Free pre-print version: Loading...

      Authors: Kimberly Velthuis, Naomi T. Jessurun, Thi D.M. Nguyen, Joep Scholl, Jurriaan R.G. Jansen, Jette A. van Lint, Leanne J. Kosse, Peter M. ten Klooster, Harald E. Vonkeman
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-01-27T10:14:52Z
      DOI: 10.1080/14740338.2023.2172157
       
  • Insights into efficacy and safety of dapagliflozin treatment for the
           management in older adults with type 2 diabetes: a systematic review and
           meta-analysis

    • Free pre-print version: Loading...

      Authors: Lili Jiang, Yanyan Jia, Xiaoyu Wang, Zhe Wang, Xin Lv, Yaqin Jia, Yuyi Feng, Hang Yin, Mingrui Yan, Xiaoyu Fan, Yong Liu
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2023-01-10T07:36:16Z
      DOI: 10.1080/14740338.2023.2166485
       
  • A multicenter, open-label, phase 3 study to evaluate the safety of
           fremanezumab for migraine, subcutaneously self-administered with an
           auto-injection device at institutional sites and at home

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Koichi Hirata, Takao Takeshima, Noboru Imai, Hisaka Igarashi, Masako Shiosakai, Masanobu Inage, Fumi Sakurai, Xiaoping Ning, Masami Nakai, Nobuyuki Koga
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-12-29T06:27:28Z
      DOI: 10.1080/14740338.2023.2162038
       
  • Treatment-related adverse events of first-line immunotherapy versus
           sorafenib for advanced hepatocellular carcinoma: a meta-analysis

    • Free pre-print version: Loading...

      Authors: Alessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, Antonio Cusmai, Mariarita Laforgia, Concetta Calabrò, Valentina Ungaro, Donato Oreste, Mario Sollitto, Gennaro Palmiotti, Giovanni Brandi
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-11-30T05:56:13Z
      DOI: 10.1080/14740338.2023.2152793
       
  • A cross-sectional study on substandard and falsified medicines (fake or
           counterfeit drugs) in UK pharmacies during the COVID-19 pandemic

    • Free pre-print version: Loading...

      Authors: Ravina Barrett
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-11-30T05:40:16Z
      DOI: 10.1080/14740338.2023.2147922
       
  • A real-world pharmacovigilance study of severe cutaneous adverse reactions
           associated with antiepileptic drug combination therapy: data mining of FDA
           adverse event reporting system

    • Free pre-print version: Loading...

      Authors: Chunyan Wei, Jingyi Zhang, Wanhong Yin, Aidou Jiang, Yin Liu, Bin Wu
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-11-16T05:53:55Z
      DOI: 10.1080/14740338.2023.2147506
       
  • Skin cancer signal associated with phosphodiesterase inhibitors: gaining
           insight through the FDA pharmacovigilance database

    • Free pre-print version: Loading...

      Authors: Jun-Wei Chow, Ming-Ming Yan, Hui Zhao, Zi-Ran Li, Qian Zhang, Ming-Kang Zhong, Xiao-Yan Qiu
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-11-12T07:22:04Z
      DOI: 10.1080/14740338.2023.2145280
       
  • Patients’ and health-care professionals’ perspectives on adverse drug
           reaction burden attributed to the use of biological DMARDs: a qualitative
           study

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Henrike J. Westerink, Leanne J. Kosse, Naomi T. Jessurun, Astrid Tubergen, Harald E. Vonkeman, Mike T. Nurmohamed, Bart J.F. van den Bemt, Marieke de Vries
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-10-25T05:42:55Z
      DOI: 10.1080/14740338.2023.2134344
       
  • Long-term safety and effectiveness of vonoprazan for prevention of gastric
           and duodenal ulcer recurrence in patients on nonsteroidal
           anti-inflammatory drugs in Japan: a 12-month post-marketing surveillance
           study

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Takashi Kawai, Chihiro Suzuki, Youichirou Honda, Jovelle L. Fernandez
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-10-20T01:28:26Z
      DOI: 10.1080/14740338.2023.2136163
       
  • Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used
           for COVID-19 based on FAERS database

    • Free pre-print version: Loading...

      Authors: Yunfei Zhao, Huiling Wang, Qingsong Zhang, Yongxin Hu, Yulong Xu, Wei Liu
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-10-07T05:32:37Z
      DOI: 10.1080/14740338.2023.2130888
       
  • A pharmacovigilance analysis of FDA adverse event reporting system events
           for romosozumab

    • Free pre-print version: Loading...

      Authors: Zepeng Chen, Ming Li, Shuzhen Li, Yuxi Li, Junyan Wu, Kaifeng Qiu, Xiaoxia Yu, Lin Huang, Guanghui Chen
      Pages: 1 - 4
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-10-06T06:00:50Z
      DOI: 10.1080/14740338.2023.2130891
       
  • Angiotensin receptor-neprilysin inhibitor and sodium-dependent glucose
           cotransporter-2 inhibitor-associated renal injury: a pharmacovigilance
           study

    • Free pre-print version: Loading...

      Authors: Chen Chen, Bin Wu, Chenyu Zhang, Ting Xu
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-09-08T05:52:46Z
      DOI: 10.1080/14740338.2022.2120609
       
  • Disproportionality analysis of adverse neurological and psychiatric
           reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2
           (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

    • Free pre-print version: Loading...

      Authors: Matilde Otero-Losada, Nikolai Petrovsky, Abdallah Alami, James A. Crispo, Donald Mattison, Francisco Capani, Christopher Goetz, Daniel Krewski, Santiago Perez-Lloret
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-09-07T07:12:40Z
      DOI: 10.1080/14740338.2022.2120607
       
  • Risk of psychiatric events in women treated with isotretinoin: a
           self-controlled study with SIDIAP database

    • Free pre-print version: Loading...

      Authors: Gemma Vona-Giralt, Carles Vilaplana-Carnerero, Dan Ouchi, Ainhoa Gomez-Lumbreras, Rosa Morros, Maria Giner-Soriano
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-09-06T05:50:54Z
      DOI: 10.1080/14740338.2022.2120608
       
  • Comparative Efficacy and safety of new targeted therapies and
           immunotherapies for metastatic triple negative breast cancer: a network
           meta-analysis

    • Free pre-print version: Loading...

      Authors: John Hang Leung, Yun-Sheng Tai, Shyh-Yau Wang, Ho Tsung-Chin, Hei-Tung Yip Fion, Agnes LF Chan, Hsu Yu-Chen
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-09-05T06:19:38Z
      DOI: 10.1080/14740338.2022.2116001
       
  • Disease-specific ADRs of TNF-α inhibitors as reported by patients with
           inflammatory rheumatic diseases: a registry-based prospective multicenter
           cohort study

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Lieke H. Roest, Leanne J. Kosse, Jette A. van Lint, Helen R. Gosselt, Joep H.G. Scholl, Eugène van Puijenbroek, Harald E. Vonkeman, Sander W. Tas, Michael T. Nurmohamed, Bart J.F. van den Bemt, Naomi T. Jessurun
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-29T05:16:25Z
      DOI: 10.1080/14740338.2022.2115479
       
  • Lack of association between febrile seizures and vaccines containing
           diphtheria, tetanus, and acellular pertussis in Chinese children

    • Free pre-print version: Loading...

      Authors: Lu Xu, Ning Li, Liang Zhang, Rui Ma, Ting Fang, Zhike Liu, Siyan Zhan
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-26T05:20:17Z
      DOI: 10.1080/14740338.2022.2116000
       
  • Pharmacovigilance regulatory actions by national pharmacovigilance centers
           in Arab countries following COVID-19 pandemic

    • Free pre-print version: Loading...

      Authors: Sameh A. Al-Zubiedi, Manal Younus, Sara Al-Khalidi, Magnus Ekilo, Thamir M. Alshammari
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-19T05:47:50Z
      DOI: 10.1080/14740338.2022.2108398
       
  • Completeness of pharmaceutical industry insulin adverse event reports from
           Africa and the Middle East

    • Free pre-print version: Loading...

      Authors: Charity RN Mlotshwa, Johanita R. Burger, Martine Vorster, Dorcas M. Rakumakoe, Marike Cockeran
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-18T04:58:10Z
      DOI: 10.1080/14740338.2022.2110863
       
  • Safety and effectiveness of empagliflozin and linagliptin fixed-dose
           combination therapy in Japanese patients with type 2 diabetes: final
           results of a one-year post-marketing surveillance study

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Nobuya Inagaki, Takaaki Nishimoto, Yoichi Nishiya, Daisuke Nitta
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-16T07:43:34Z
      DOI: 10.1080/14740338.2022.2107200
       
  • Analysis and visualization of the course and burden over time of adverse
           drug reactions (ADRs) attributed to TNFα-inhibitors in patients with
           inflammatory rheumatic diseases (IRDs)

    • Free pre-print version: Loading...

      Authors: Merel de Boer, Helen R Gosselt, Jurriaan Jansen, Martijn B.A van Doorn, Frank Hoentjen, Michael T Nurmohamed, Phyllis I Spuls, Sander W Tas, Harald E Vonkeman, Naomi T Jessurun
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-10T11:49:52Z
      DOI: 10.1080/14740338.2022.2110237
       
  • Immune checkpoint inhibitors increase the risk of kidney transplant
           rejection: a real-world pharmacovigilance study

    • Free pre-print version: Loading...

      Authors: Junyan Wu, Jianxiang Huang, Jianhong Zhu, Zhichao He, Mengting Chen, Siyuan Gao, Dan Liang, Xiaoxia Yu, Chengyu Lu
      Pages: 1 - 5
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-09T01:18:43Z
      DOI: 10.1080/14740338.2022.2110234
       
  • Interstitial pneumonitis associated with EGFR/ ALK tyrosine kinase
           inhibitors used in non–small cell lung cancer: an observational,
           retrospective, pharmacovigilance study

    • Free pre-print version: Loading...

      Authors: Zhuo Ma, Jie Pei, Yi Zhang, Hao Li, Dan Sun, Yuhui Zhang, Zhuoling an
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-05T03:18:17Z
      DOI: 10.1080/14740338.2022.2110235
       
  • Safety and tolerability of spesolimab in patients with ulcerative colitis

    • Free pre-print version: Loading...

      Authors: Marc Ferrante, Peter M Irving, Christian P Selinger, Geert D’Haens, Tanja Kuehbacher, Ursula Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus, Brian G. Feagan
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-08-01T05:51:56Z
      DOI: 10.1080/14740338.2022.2103536
       
  • Safety profile of lasmiditan in patients with migraine in an Asian
           population

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Koichi Hirata, Yasuhiko Matsumori, Yuka Tanji, Rashna Khanna, Akichika Ozeki, Mika Komori
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-07-13T06:14:02Z
      DOI: 10.1080/14740338.2022.2087630
       
  • Effect of omega-3 fatty acids on cardiovascular events in high-risk
           patients with hypertriglyceridemia in Japan: a 3-year post-marketing
           surveillance study (OCEAN3 survey)

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Tamio Teramoto, Hisao Ogawa, Hirotsugu Ueshima, Yasushi Okada, Kazuo Haze, Shigeyuki Matsui, Keita Fujikawa, Takamasa Hashimoto, Sho Sakui, Kunihiko Nishimura, Mika Kajita, Atsushi Horimoto, Jovelle Fernandez
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-07-08T04:45:59Z
      DOI: 10.1080/14740338.2022.2094914
       
  • Hydroxychloroquine safety in Covid-19 vs non-Covid-19 patients: analysis
           of differences and potential interactions

    • Free pre-print version: Loading...

      Authors: María Sainz-Gil, Nieves Merino Kolly, Verónica Velasco-González, Zoraida Verde Rello, Ana M Fernandez-Araque, Rosario Sanz Fadrique, Luis H Martín Arias
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Drug Safety
      PubDate: 2022-05-20T05:15:08Z
      DOI: 10.1080/14740338.2022.2078303
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 18.205.66.93
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-